Topping the list of new billionaires are Moderna (MRNA)
CEO Stéphane Bancel and Ugur Sahin, the CEO of BioNTech (BNTX)
, which has produced a vaccine with Pfizer (PFE)
. Both CEOs are now worth around $4 billion, according to an analysis
by the People’s Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International.
Senior executives from China’s CanSino Biologics and early investors in Moderna have also become billionaires on paper as shares skyrocketed, partly in expectation of profits earned from Covid vaccines
, which also bode well for the companies’ future prospects. The analysis was compiled using data from the Forbes Rich List
Moderna’s share price has gained more than 700% since February 2020, while BioNTech has surged 600%. CanSino Biologics’ stock is up about 440% over the same period. The company’s single-dose Covid-19 vaccine was approved for use in China in February.